Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.4% |
| 2 | Technology | 18.51% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Financials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Mannatech
MTEX
$9.84M
| $844K | ﹤0.01% |
40,599
-17,000
| -30% | -$343K |
|
|
REVG
2602
DELISTED
REV Group
REVG
| $842K | ﹤0.01% |
76,300
-5,500
| -7% | -$63.2K |
|
|
PVLA
2603
Palvella Therapeutics
PVLA
$2.28B
| $841K | ﹤0.01% |
9,139
+1,888
| +26% | +$243K |
|
2604
Fabrinet
FN
$20.1B
| $840K | ﹤0.01% |
+8,800
| New | +$847K |
|
2605
Carter Bankshares
CARE
$744M
| $837K | ﹤0.01% |
52,000
-63,000
| -55% | -$985K |
|
|
DHC
2606
Diversified Healthcare Trust
DHC
$2.13B
| $837K | ﹤0.01% |
845,700
-717,600
| -46% | -$1.15M |
|
|
FRGE
2607
DELISTED
Forge Global Holdings
FRGE
| $837K | ﹤0.01% |
31,892
+26,392
| +480% | +$1.81M |
|
2608
Cimpress
CMPR
$2.38B
| $835K | ﹤0.01% |
34,100
-7,200
| -17% | -$246K |
|
|
REE
2609
DELISTED
REE Automotive
REE
| $834K | ﹤0.01% |
40,810
+16,407
| +67% | +$564K |
|
2610
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
| $831K | ﹤0.01% |
+11,900
| New | +$915K |
|
2611
Ring Energy
REI
$333M
| $829K | ﹤0.01% |
357,539
-338,561
| -49% | -$924K |
|
2612
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.76B
| $828K | ﹤0.01% |
20,800
+100
| +0.5% | +$4.42K |
|
2613
Vanguard Russell 2000 Growth ETF
VTWG
$1.54B
| $827K | ﹤0.01% |
5,500
-500
| -8% | -$81.8K |
|
2614
Global Net Lease
GNL
$1.92B
| $826K | ﹤0.01% |
77,600
+44,102
| +132% | +$614K |
|
2615
AtaiBeckley Inc
ATAI
$2.67B
| $822K | ﹤0.01% |
248,300
-179,900
| -42% | -$739K |
|
2616
iShares Global REIT ETF
REET
$5.11B
| $821K | ﹤0.01% |
38,600
-14,800
| -28% | -$365K |
|
|
EWCZ
2617
DELISTED
European Wax Center
EWCZ
| $820K | ﹤0.01% |
44,427
-13,173
| -23% | -$259K |
|
2618
iShares MSCI World ETF
URTH
$8.25B
| $820K | ﹤0.01% |
8,200
-100
| -1% | -$11.1K |
|
2619
CION Investment
CION
$368M
| $819K | ﹤0.01% |
96,300
+23,200
| +32% | +$218K |
|
|
OGI
2620
Organigram Holdings
OGI
$139M
| $817K | ﹤0.01% |
234,400
-33,838
| -13% | -$142K |
|
|
SELF
2621
Global Self Storage
SELF
$59.6M
| $816K | ﹤0.01% |
139,200
-7,100
| -5% | -$40.7K |
|
2622
HUTCHMED
HCM
$2.14B
| $815K | ﹤0.01% |
91,952
-324,700
| -78% | -$4.09M |
|
|
ZYNE
2623
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $813K | ﹤0.01% |
1,110,035
+373,435
| +51% | +$424K |
|
|
CDTX
2624
DELISTED
Cidara Therapeutics
CDTX
| $812K | ﹤0.01% |
64,664
+6,851
| +12% | +$94.6K |
|
2625
MicroSectors Gold Miners 3x Leveraged ETN
GDXU
$1.09B
| $811K | ﹤0.01% |
+27,570
| New | +$1.04M |
|
Similar funds
Renaissance Technologies's Q3 2022 Portfolio in Review
As of Q3 2022, Renaissance Technologies held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class A worth $498M.
- Renaissance Technologies's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Renaissance Technologies added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Renaissance Technologies's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Renaissance Technologies fully exited Shopify in Q3 2022, selling an estimated $439M.
- Renaissance Technologies's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Renaissance Technologies opened 441 new positions and closed 637 in Q3 2022.
- Renaissance Technologies's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.